This is an ongoing study done in National 
Introduction:
Coronary angioplasty was first introduced by Andreas Gruentzig in 1977 as a non-surgical method for coronary arterial revascularisation 1 . Fundamentally the technique involved advancing a balloon tipped catheter to an area of coronary narrowing, inflating the balloon & then removing the catheter following deflation. Early reports demonstrated that balloon angioplasty could reduce the severity of coronary stenosis & diminish or eliminate objective & subjective manifestations of myocardial ischemia [2] [3] [4] . Though angioplasty is clearly feasible & effective, the scope of doing coronary angioplasty was quite narrow. Angioplasty could result in sudden arterial occlusion & subsequently myocardial infarction (MI), so immediate access to coronary bypass surgery was essential 5 . However with experience & time, the cognitive & technical aspects used to perform angioplasty could be applied to a broad groups of coronary patients with higher rate of success & lower rates of complications when compared to initial experience [6] [7] . More than 5,00000 PCI procedures are performed yearly in the US 8 & it has been estimated that more than 10,00,000 procedures are performed annually worldwide. The Indication of PCI were unstable angina, Post myocardial infraction angina of variable duration (Table-1 ). The age range of the patients were from 29 yrs to 81 years with a mean of 50.50 ± 8.69 yrs. Of the six hundred patients 50 female & 550 male with a male female ratio of 11:1 Inclusion Criteria were symptomatic coronary artery disease of angina NYHA class II to IV of both sexes, having no age limitation. The risk factors were hypertension 52% (310 cases), Smoking 71% (426 cases), Diabetes Mellitus 30% (180 cases), Dyslipidaemia 25% (150 cases), and positive family history of ischemic heart disease 20% (120 cases). Left ventricular ejection fraction (EF) was as low as 29% with a mean of 41 ± 12.5%.
Definition of PCI:
Out of 600 patients number of diseased coronary artery was 760, of which target lesion was 803. Stent was deployed in 725 lesions of 660 coronary arteries. Plain balloon angioplasty was done in 34 cases. Mean Coronary artery diameter was 3.03 ± 0.61 mm. No stent was deployed if vessels caliber less than 2.25 mm or lesion length >34 mm, in cases of extreme tortuousity and with large thrombus at the site of the lesion.
Procedure:
Angioplasty was done as elective & adhoc basis. Almost all of the procedures were done through right femoral arterial approach, except few cases done by right radial approach, in most cases as single wall puncture technique using 7F & 6F guiding catheters most frequently Judkins type, in some cases with Extra back up catheters, Voda catheters, Amplatz left & right catheters with premedications of aspirin, clopidogrel & heparin in some cases. During the beginning of procedure an IV bolus of 10,000 units heparin was given followed by 5000 unit hourly & ACT was maintained around 300 sec during the whole procedure. In most of the cases (70%) the lesions were predilated by stent balloons except few cases of chronic total occlusion & heavily calcified lesion which required 1.5mm new balloon & graded dilatation was done before deploying stents. Balloon expandable stents were used in/ all the cases. Femoral sheaths were removed within 4-6 hours of the procedure. Following procedure heparin was not used except multivessel angioplasties, complex lesions, chronic total occlusions, minor edge dissections. Clopidogrel was used in all patients 150 mg daily. During hospital discharge all patients were prescribed with aspirin 150 mg daily, Clopidogrel 150 mg daily & other anti ischemic therapy as required.
Result :
Our total study population was 600 with age range 29-81 years mean 50.50 ± 8.69 yrs. 550 patients were male & 50 female (Table-1 ). Risk factors were HTN 52%, DM 30%, smoking 71%, Hyperlipidemia 25%, positive family history 20%. Clinical diagnosis of patients was unstable angina without prior MI 40% post MI angina 60% (anterior MI with post MI angina 26% & inferior MI with post MI angina 34%). Angiographic diagnosis was single vessel disease 52% double vessel disease 26% & triple vessel disease 22%. Out of 600 patients, in 15 cases wire not passed, in 5 cases PTCA wire was negotiated but the PTCA balloon did not cross the lesion, in 3 cases wire negotiated, balloon passed & lesion dilated but stent did not cross lesions, in one case wire crossed, balloon passed & lesion dilated but no TIMI flow improvement, so considered as failed PTCA.
All the stents were implanted successfully except two in our initial experience. First one was a bare stent mounted on a 2.5 x 15mm balloon & the stent was embolized in , the mid LCX & subsequently CABG was done in that particular case. Second one was a case of 70% Proximal LAD lesion that was predilated. Then 3.OX9 mm stent passed through the lesion. Stent was inflated twice at 8-10 atm. But stent did not inflated, and then we decided to take out the stent. Accordingly stent was pulled back but did not come back; it is dislodged in the LAD at ostium.
Then we passed a 1.5 mm new balloon through the stent and pushed the stent to the proper site of lesion, inflated up to 20 atm. Again a 2.5 mm balloon passed through the stent and inflated up to 16 atm. Finally 3.0 x 10 mm balloon passed through the stent and inflated up to 16 atmosphere and the stent was matched appropriately both proximally and distally. (Table-V) . Four patients developed acute LVF on the table & were managed with IV nitrate, IV frusemide immediately. One patient died suddenly 2 hours after the procedure due to sudden arrhythmia and one patient died on the 4 t " day of procedure due to massive intraperitoneal hemorrhage causing irreversible shock & acute renal failure. Both these patients were female.
During the procedure of PCI in a pt. of double vessel disease (DVD), after deploying stents in LAD, same wire was passed to the LCX. After crossing the proximal part of the lesion wire was neither advancing forward, nor coming back. We tried to pull back the wire in different technique but all in vain. It was found that the tip of the wire has passed through the plaque into a small side branch. When we pulled it a bit strongly then the radiopaque portion of the wire is broken & remains within the coronary artery. Then we tried to withdraw the wire by introducing further two wires & made intertwined with the broken wire but failed. Then we tried with coronary snare but also failed. Finally we crossed the lesion by a new wire & dilated the lesion. After predilatation we implant a longer stent 2.5 x 28 to cross the lesion & entire portion of the broken wire was fixed with the wall. Total occlusion was 14.11 ( Table-1 
TABLE NO-VII RESULTS

No of target vessel 760
No of target lesions 803
No of treated lesions 780
No of stents deployed 795
No of failed PCI 24
No of POBA 34
Discussion:
From our result it is found that in most of the indicated cases, PCI can be done efficiently with very minimum rate of failure & complication. In hospital mortality was only 0.50% with 1% periprocedural myocardial infraction and three emergency CABG-one case where stent dislodgment occurred, one was due to sub acute stent thrombosis and one was due to failed PCI. Thrombolytics in AMI can establish TIMI III flow in 40-60% cases depending in the various regimens as well as the time duration of starting the thrombolytics from the onset of the symptoms. On the other hand if a patient can be taken to the catheter laboratory by 12 hours, primary angioplasty 17, 18 , can achieve TIMI III flow in 80-90% of cases. Primary angioplasty is more effective than thrombolysis, with a significant lower risk of cerebral bleeding; better early patency rate leading to improved left ventricular function.
A. Definitions of PCI Success
A. The success of a PCI procedure may have the following components-angiographic success, procedural success & clinical success.
1. Angiographic success -A successful PCI produces substantial enlargement of the lumen at the target site. Previously definition was the achievement of a minimum stenosis diameter reduction to <50% in the presence of grade 3 TIMI flow 16 . With the advent of advanced adjunct technology, including coronary stents, a minimum stenosis diameter reduction to <20% has been the bench mark of an optimal angiographic result. 19, 20, 21. In addition dynamic change in vessel size or lack of complimentary enlargement has been implicated 22 . Definitions of restenosis at follow-up angiography have been most frequently used.
Other factors responsible for restenosis are clinical conditions like DM unstable angina, acute MI prior restenosis [22] [23] , angiographic factors like proximal left anterior descending artery, small vessel diameters, total occlusion; long lesion length, SVG 29 , & the procedural factors e.g.: higher post procedure percent diameter, bifurcation lesion, smaller acute gain 30 have been associated with an increased incidence of restenosis. Recently developed drug coated stents have reduced the incidence of restenosis drastically to 0-4%. Ten years follow up of initial cohort of patients treated with PTCA revealed 89.5% survival rate (95% with single vessel disease, 81% in patients with multivessel disease 25 . In patients undergoing with the 1985-1986 NHLBL PTCA registry 30 a five year survival was 92.9% for patients with single vessel disease, 88.5% for double vessel disease & 86.5 % for triple vessel disease. In patients with multivessel disease undergoing PTCA in BAR 1, a 5-year survival was 86.3%, infarct free survival was 78.7%. Specifically 5-year survival was 84.7% with TVD, 87.6% with DVD (Double vessel disease). With the advent of novel drug eluting stents the indication of PCI has changed. Now a days randomly PCI done to Left main coronary artery, osteal lesions bifurcation lesions, multivessel diseases, complex lesions. The result is also favourable. Though in our setting there is some lack of logistic support like intra aortic balloon pump (IABP), intravascular ultrasound (IVUS) so we are, a bit behind which is the real scenario, even in this context we are doing PCI well with Complex lesions, bifurcation lesions, Ostial lesions. Hopefully within short time we shall not remain behind in the field of PCI with developed countries.
Conclusion:
In the field of management of coronary artery disease percutaneous coronary intervention (PCI) is the internationally recognized standard treatment worldwide for near about 3 decades. Our result of PCI correlates well with the other studies worldwide, though the study population is small & there are many lacks of logistics in our country. However the additional iatrogenic mechanical injury to coronary atherosclerosis initiate a new disease process restenosis in a few cases approximately 10-15%, though with the advent of drug coated stents like sirolimous coated BX velocity balloon expandable stent & paclitaxel-eluting stents has overcome the major adverse effect like restenosis. Though these stents are very costly for our developing country, but hope that in near future it will come within our reach. These stents can give only the benefit of preventing in stent restenosis leaving the remaining entire coronary systems to atherosclerosis. So it should be a combined duty of interventionist & patients to prevent occurrence of further coronary artery lesion including the life style modification, strict control of HTN, DM, and SMOKING. Modifiable risk factor control is one of the important fates of success of intervention.
